Evidence map›Paper›PMID 24467814›Full record

ArticleMolecular autism2014

Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population.

Nori Matsunami, Charles H Hensel, Lisa Baird, Jeff Stevens, Brith Otterud, Tami Leppert, Tena Varvil, Dexter Hadley, Joseph T Glessner, Renata Pellegrino and 11 more

Open access · goldAbstract read
In one paragraph

Article in Molecular autism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Whole exome sequencing reveals a dual diagnosis ofMolecular genetics and metabolism reports · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. A rigorousFrontiers in molecular neuroscience · 2022
    Article
  7. Developmentally regulated GTPases: structure, function and roles in disease.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. The small members of the JMJD protein family: Enzymatic jewels or jinxes?Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Nori Matsunami *Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Charles H Hensel *Lineagen, Inc, Salt Lake City, UT, USA.
Lisa BairdDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Jeff StevensDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Brith OtterudDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Tami LeppertDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Tena VarvilDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Dexter HadleyCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Joseph T GlessnerCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Renata PellegrinoCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Cecilia KimCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kelly ThomasCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Fengxiang WangCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Frederick G OtienoCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Karen HoLineagen, Inc, Salt Lake City, UT, USA.
Gerald B ChristensenGolden Helix, Inc, Bozeman, MT, USA.
Dongying LiDepartment of Cell and Developmental Biology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Rytis PrekerisDepartment of Cell and Developmental Biology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Christophe G LambertGolden Helix, Inc, Bozeman, MT, USA.
Hakon HakonarsonCenter for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Mark F LeppertDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Children's Hospital of Philadelphia · USUniversity of Utah · USDouble Helix (United States) · USLineage Cell Therapeutics (United States) · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · US

Funding

Integrative Analysis of a GWAS Repository with EMRs from over 40,000 ChildrenU01HG006830 · NHGRI · CHILDREN'S HOSP OF PHILADELPHIA · PI HAKONARSON, HAKON · 2012 to 2014
$3.7M
NHGRI NIH HHS U01 HG006830
6 · The paper itself

Abstract

backgroundGenetics clearly plays a major role in the etiology of autism spectrum disorders (ASDs), but studies to date are only beginning to characterize the causal genetic variants responsible. Until recently, studies using multiple extended multi-generation families to identify ASD risk genes had not been undertaken.

methodsWe identified haplotypes shared among individuals with ASDs in large multiplex families, followed by targeted DNA capture and sequencing to identify potential causal variants. We also assayed the prevalence of the identified variants in a large ASD case/control population.

resultsWe identified 584 non-conservative missense, nonsense, frameshift and splice site variants that might predispose to autism in our high-risk families. Eleven of these variants were observed to have odds ratios greater than 1.5 in a set of 1,541 unrelated children with autism and 5,785 controls. Three variants, in the RAB11FIP5, ABP1, and JMJD7-PLA2G4B genes, each were observed in a single case and not in any controls. These variants also were not seen in public sequence databases, suggesting that they may be rare causal ASD variants. Twenty-eight additional rare variants were observed only in high-risk ASD families. Collectively, these 39 variants identify 36 genes as ASD risk genes. Segregation of sequence variants and of copy number variants previously detected in these families reveals a complex pattern, with only a RAB11FIP5 variant segregating to all affected individuals in one two-generation pedigree. Some affected individuals were found to have multiple potential risk alleles, including sequence variants and copy number variants (CNVs), suggesting that the high incidence of autism in these families could be best explained by variants at multiple loci.

conclusionsOur study is the first to use haplotype sharing to identify familial ASD risk loci. In total, we identified 39 variants in 36 genes that may confer a genetic risk of developing autism. The observation of 11 of these variants in unrelated ASD cases further supports their role as ASD risk variants.

Identifiers

PMID24467814
PMCPMC4098669
OpenAlexW2110364060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.